Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI South East AsiaCPhI South East Asia
Not Confirmed
Not Confirmed
16-18 July, 2025
Specialty & Agro Chemi...Specialty & Agro Chemical
Not Confirmed
Not Confirmed
29 June-01 July, 2025
Discovery EuropeDiscovery Europe
Not Confirmed
Not Confirmed
01-02 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI South East AsiaCPhI South East Asia
Industry Trade Show
Not Confirmed
16-18 July, 2025
Specialty & Agro Chemi...Specialty & Agro Chemical
Industry Trade Show
Not Confirmed
29 June-01 July, 2025
Discovery EuropeDiscovery Europe
Industry Trade Show
Not Confirmed
01-02 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/j-j-s-intra-cellular-buyout-bms-oncology-gambit-sanofi-s-blueprint-acquisition-drive-mega-deals-in-h1-2025
03 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/therapeutic-goods-administration-decides-not-to-register-lecanemab-in-australia-302389834.html
01 Mar 2025
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/eu-regulator-not-updating-opinion-eisai-biogens-alzheimers-drug-2025-02-28/
27 Feb 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/eisai-part-ways-121-employees-amid-new-us-restructuring-effort
14 Nov 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761269
02 Jul 2024
// Nick Paul Taylor FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/bms-axes-eisai-adc-pact-3-years-after-paying-650m-would-be-elahere-rival
28 Jun 2024
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/eisai-biogen-launch-alzheimers-drug-leqembi-china-2024-06-28/
Inspections and registrations
ABOUT THIS PAGE
Eisai Inc is a supplier offers 3 products (APIs, Excipients or Intermediates).
Find a price of MOH040 bulk with DMF offered by Eisai Inc
Find a price of INTERLEUKIN-2 DIPHTHERIA TOXIN FUSION PROTEIN (DAB 389 IL-2) bulk offered by Eisai Inc
Find a price of Eperisone Hydrochloride bulk offered by Eisai Inc